Regencell Bioscience Holdings (RGC) Shares Outstanding (Diluted Average) (2020 - 2023)
Regencell Bioscience Holdings (RGC) reported Shares Outstanding (Diluted Average) of $494.5 million for Q2 2023, up 4844.89% quarter-over-quarter from $10.0 million in Q2 2020.
Regencell Bioscience Holdings (RGC) Shares Outstanding (Diluted Average) (2020 - 2023) Analysis & Trends
Regencell Bioscience Holdings has reported Shares Outstanding (Diluted Average) for 2 years, with the latest figure at $494.5 million in Q2 2023.
- For the quarter ending Q2 2023, Shares Outstanding (Diluted Average) changed N/A year-over-year to $494.5 million; the trailing twelve-month figure through Jun 2023 stood at $494.5 million (changed N/A YoY), and the FY2023 full-year result was $494.5 million, changed N/A from the prior year.
- Shares Outstanding (Diluted Average) for Q2 2023 stood at $494.5 million, up from $10.0 million in the prior quarter.
- The five-year high for Shares Outstanding (Diluted Average) was $494.5 million in Q2 2023, with the low at $10.0 million in Q2 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Diluted Avg.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.97 Bn | 36.23 Bn | 1.97 Bn | 1.18 Bn |
| 2 | Zoetis | 33.59 Bn | 31.65 Bn | 1.62 Bn | 422.40 Mn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 47.20 Mn |
| 4 | Neurocrine Biosciences | 16.10 Bn | 14.78 Bn | 800.70 Mn | 103.40 Mn |
| 5 | Aurora Cannabis | 15.56 Bn | 15.47 Bn | 21.72 Mn | - |
| 6 | Elanco Animal Health | 12.04 Bn | 11.61 Bn | 785.00 Mn | 506.00 Mn |
| 7 | Alkermes | 7.36 Bn | 6.84 Bn | -116.06 Mn | - |
| 8 | Lantheus Holdings | 6.74 Bn | 6.24 Bn | 230.92 Mn | - |
| 9 | Liquidia | 6.27 Bn | 6.04 Bn | 121.79 Mn | 101.11 Mn |
| 10 | Regencell Bioscience Holdings | - | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 494.49 Mn |
| Jun 30, 2020 | 10.00 Mn |